Find policies, billing codes, payers, states, and providers

CPT 0521U: Seronegative Rheumatoid Arthritis Panel

CPT code 0521U designates a Proprietary Laboratory Analyses (PLA) test: the Seronegative Rheumatoid Arthritis Panel from KSL Diagnostics–Beutner Laboratories Inc. and KSL Biomedical Inc. The panel measures rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) via immunoassay, supporting diagnosis and evaluation of patients with suspected seronegative rheumatoid arthritis. As a PLA code, 0521U is specific to a single manufacturer’s assay and is used when that exact test is performed.

This publication addresses national implications for clinicians, laboratorians, and payers. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the analytes included in the panel, typical settings where the service is performed, and an overview of reimbursement and coverage topics relevant to proprietary laboratory tests. The report summarizes benchmarks and payer coverage patterns where available, highlights policy considerations around PLA codes, and explains how 0521U fits within laboratory service line billing. Data not available in the input are noted where applicable.

Customize your policy alerts

Sign up for cpt 0521U policy alerts

Get alerted when payer policies referencing 0521U are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

CPT code 0521U is a Proprietary Laboratory Analyses (PLA) code that applies to a single laboratory test: the Seronegative Rheumatoid Arthritis Panel offered by KSL Diagnostics–Beutner Laboratories Inc. and KSL Biomedical Inc. The test assesses serologic markers used in rheumatoid arthritis evaluation, measuring rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) using immunoassay technology.

Service Type: Laboratory immunoassay panel for rheumatoid arthritis serology

Typical Site of Service: Clinical laboratory or reference laboratory; specimen collection may occur in outpatient clinics or physician offices

Explore openpayer tools

View all tools

Find policies, billing codes, payers, states, and providers

CPT 0521U: Seronegative Rheumatoid Arthritis Panel

Customize your policy alerts

Sign up for cpt 0521U policy alerts

Get alerted when payer policies referencing 0521U are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service Type: Laboratory immunoassay panel for rheumatoid arthritis serology

Typical Site of Service: Clinical laboratory or reference laboratory; specimen collection may occur in outpatient clinics or physician offices

Clinical & Coding Specifications

Clinical Context

A 47-year-old patient presents to a rheumatology clinic with a 6-month history of persistent symmetric polyarthralgia, morning stiffness lasting more than one hour, intermittent swelling of small hand joints, and negative standard serologic tests for rheumatoid arthritis (negative rheumatoid factor IgM on routine testing and negative anti-CCP by prior lab). The clinician suspects seronegative rheumatoid arthritis given clinical exam and imaging showing early erosive changes on hand radiographs. The rheumatologist orders the proprietary Seronegative Rheumatoid Arthritis Panel (0521U) from KSL Diagnostics–Beutner Laboratories Inc. to measure rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) using immunoassay technology.

Specimen collection, labeling, and transport follow outpatient phlebotomy protocols; the laboratory performs the proprietary immunoassays, reports quantitative and qualitative results, and sends a report to the ordering provider. Results are used to support or refine the diagnosis, guide discussions about initiation of disease-modifying antirheumatic drug therapy, and document objective serologic findings in the patient record. Typical site of service for ordering and specimen collection is an outpatient clinic, ambulatory infusion center, or independent phlebotomy draw station; testing is performed at the manufacturer-specific clinical laboratory that developed the PLA test.

Coding Specifications

Modifier	Description	When to Use
`00`	Procedural modifier: default/status indicator (use per payer rules)	Used when no specific distinct modifier applies and payer requires a status indicator code; follow payer guidance.
`22`	Increased procedural services	Used when documentation supports services substantially greater than typical for the laboratory testing process (rare for PLA reporting; typically not used for standard lab panels).
`26`	Professional component	Used if reporting only the professional interpretation component when applicable and payer requires split billing between professional and technical components.
`52`	Reduced services	Used when the laboratory test is partially performed or limited compared to the full panel (document reason for reduction).
`53`	Discontinued procedure	Used when specimen collection or testing was started but discontinued for clinical reasons prior to completion.
`TC`	Technical component	Used to report only the technical component (laboratory processing, materials) if professional component billed separately.

Taxonomy Code	Specialty	Notes
207RH0000X	Rheumatology	Specialists ordering serologic panels for inflammatory arthritis diagnosis.
208D00000X	Diagnostic Laboratory	Clinical laboratory performing proprietary immunoassays and reporting results.
2080P0005X	Pathology & Laboratory Medicine	Laboratory medicine specialists overseeing assay validation and interpretation standards.
207LP2900X	Internal Medicine	Primary care or general internists who may order the panel during diagnostic workup of inflammatory arthritis.
207RI0001X	Pediatric Rheumatology	Pediatric rheumatologists ordering serologic testing for juvenile idiopathic arthritis cases with seronegative features.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M06.0`	Rheumatoid arthritis with rheumatoid factor	Differential diagnosis; serologic testing helps distinguish seropositive vs seronegative disease.
`M06.9`	Rheumatoid arthritis, unspecified	Common diagnostic label during initial evaluation when serology is pending or inconclusive.
`M06.8`	Other rheumatoid arthritis with rheumatoid factor	Used for variant RA presentations; serologic panel can clarify antibody status.
`M12.0`	Seronegative spondyloarthritis	Differential consideration for seronegative inflammatory arthritides; testing may help exclude RA.
`R68.89`	Other general symptoms and signs; includes constitutional symptoms	Symptoms such as fatigue and malaise often accompany inflammatory arthritis and prompt broader testing.
`M79.0`	Rheumatism, unspecified and other soft tissue disorders, not elsewhere classified	Symptom-driven testing when joint pain is present but specific diagnosis pending.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80054`	Chemistry panel; comprehensive metabolic panel	Often ordered concurrently to assess baseline organ function before initiating disease-modifying therapy guided by serologic results.
`86318`	Immunoassay for infectious agent antibody, quantitative (example code for immunoassays)	Represents the general class of immunoassay methodology; `0521U` is a PLA specific to a manufacturer using immunoassay technology.
`86431`	Antibody; rheumatoid factor, quantitation	Standard rheumatoid factor quantitative testing that may be ordered alongside or prior to the proprietary seronegative panel for comparison.
`86255`	Antibody; cyclic citrullinated peptide (CCP), qualitative or semi-quantitative	Common anti-CCP testing; the PLA `0521U` measures CCP antibodies as part of a proprietary panel.
`99000`	Handling and/or conveyance of specimen for transfer from physician to laboratory (This is an example non-billable code — use payer guidelines)	Relates to specimen handling and transport logistics when specimens are sent to the specialized laboratory performing the PLA test.

CPT 0001U: PreciseType HEA Multiplex Erythrocyte Antigen Assay

CPT-0002U-POLYPDX-URINE-METABOLOMIC-ASSAY-ADENOMATOUS-POLYP-RISK

CPT 0002U: Urine Metabolomic Polyp Risk Assay (PolypDX™)

CPT-0003U-OVAR-A-NEXT-GENERATION-OVARIAN-CANCER-RISK-ASSAY

CPT 0003U: Overa™ (OVA1 Next Generation) Ovarian Cancer Risk Assay

CPT-0005U-PROSTATE-EXOSOMEDX-INTELLISCORE-GENE-EXPRESSION-URINE-TEST

CPT 0005U: ExosomeDx Prostate (IntelliScore) Urine Gene Expression Risk Test

CPT-0007U-TOXPROTECT-URINE-DRUG-SCREEN-WITH-DNA-AUTHENTICATION

CPT 0007U: ToxProtect Urine Drug Screen with DNA Authentication

CPT-0008U-H-PYLORI-ANTIBIOTIC-RESISTANCE-SEQUENCING-PANEL

CPT 0008U: H. pylori Antibiotic Resistance Panel, Gene Sequence Analysis

CPT-0009U-DEPARRAY-HER2-FISH-TUMOR-CELL-ISOLATION

CPT 0009U: DEPArray HER2 Tumor‑Cell Isolation with FISH Analysis

CPT-0010U-BACTERIAL-TYPING-WHOLE-GENOME-SEQUENCING-MAYO-CLINIC

CPT 0010U: Bacterial Typing by Whole Genome Sequencing, Mayo Clinic

CPT-0011U-CORDANT-CORE-ALGORITHMIC-ORAL-FLUID-DRUG-TEST

CPT 0011U: Cordant CORE™ Oral Fluid Drug Test with Algorithmic Steady‑State Comparison

CPT-0016U-BCR-ABL1-MAJOR-MINOR-FUSION-TRANSCRIPT-TESTING

CPT 0016U: BCR–ABL1 Major and Minor Breakpoint Fusion Transcript Testing

Showing 1–10 of 536

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`00`	Procedural modifier: default/status indicator (use per payer rules)	Used when no specific distinct modifier applies and payer requires a status indicator code; follow payer guidance.
`22`	Increased procedural services	Used when documentation supports services substantially greater than typical for the laboratory testing process (rare for PLA reporting; typically not used for standard lab panels).
`26`	Professional component	Used if reporting only the professional interpretation component when applicable and payer requires split billing between professional and technical components.
`52`	Reduced services	Used when the laboratory test is partially performed or limited compared to the full panel (document reason for reduction).
`53`	Discontinued procedure	Used when specimen collection or testing was started but discontinued for clinical reasons prior to completion.
`TC`	Technical component	Used to report only the technical component (laboratory processing, materials) if professional component billed separately.

Taxonomy Code	Specialty	Notes
207RH0000X	Rheumatology	Specialists ordering serologic panels for inflammatory arthritis diagnosis.
208D00000X	Diagnostic Laboratory	Clinical laboratory performing proprietary immunoassays and reporting results.
2080P0005X	Pathology & Laboratory Medicine	Laboratory medicine specialists overseeing assay validation and interpretation standards.
207LP2900X	Internal Medicine	Primary care or general internists who may order the panel during diagnostic workup of inflammatory arthritis.
207RI0001X	Pediatric Rheumatology	Pediatric rheumatologists ordering serologic testing for juvenile idiopathic arthritis cases with seronegative features.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M06.0`	Rheumatoid arthritis with rheumatoid factor	Differential diagnosis; serologic testing helps distinguish seropositive vs seronegative disease.
`M06.9`	Rheumatoid arthritis, unspecified	Common diagnostic label during initial evaluation when serology is pending or inconclusive.
`M06.8`	Other rheumatoid arthritis with rheumatoid factor	Used for variant RA presentations; serologic panel can clarify antibody status.
`M12.0`	Seronegative spondyloarthritis	Differential consideration for seronegative inflammatory arthritides; testing may help exclude RA.
`R68.89`	Other general symptoms and signs; includes constitutional symptoms	Symptoms such as fatigue and malaise often accompany inflammatory arthritis and prompt broader testing.
`M79.0`	Rheumatism, unspecified and other soft tissue disorders, not elsewhere classified	Symptom-driven testing when joint pain is present but specific diagnosis pending.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80054`	Chemistry panel; comprehensive metabolic panel	Often ordered concurrently to assess baseline organ function before initiating disease-modifying therapy guided by serologic results.
`86318`	Immunoassay for infectious agent antibody, quantitative (example code for immunoassays)	Represents the general class of immunoassay methodology; `0521U` is a PLA specific to a manufacturer using immunoassay technology.
`86431`	Antibody; rheumatoid factor, quantitation	Standard rheumatoid factor quantitative testing that may be ordered alongside or prior to the proprietary seronegative panel for comparison.
`86255`	Antibody; cyclic citrullinated peptide (CCP), qualitative or semi-quantitative	Common anti-CCP testing; the PLA `0521U` measures CCP antibodies as part of a proprietary panel.
`99000`	Handling and/or conveyance of specimen for transfer from physician to laboratory (This is an example non-billable code — use payer guidelines)	Relates to specimen handling and transport logistics when specimens are sent to the specialized laboratory performing the PLA test.

CPT 0001U: PreciseType HEA Multiplex Erythrocyte Antigen Assay

CPT-0002U-POLYPDX-URINE-METABOLOMIC-ASSAY-ADENOMATOUS-POLYP-RISK

CPT 0002U: Urine Metabolomic Polyp Risk Assay (PolypDX™)

CPT-0003U-OVAR-A-NEXT-GENERATION-OVARIAN-CANCER-RISK-ASSAY

CPT 0003U: Overa™ (OVA1 Next Generation) Ovarian Cancer Risk Assay

CPT-0005U-PROSTATE-EXOSOMEDX-INTELLISCORE-GENE-EXPRESSION-URINE-TEST

CPT 0005U: ExosomeDx Prostate (IntelliScore) Urine Gene Expression Risk Test

CPT-0007U-TOXPROTECT-URINE-DRUG-SCREEN-WITH-DNA-AUTHENTICATION

CPT 0007U: ToxProtect Urine Drug Screen with DNA Authentication

CPT-0008U-H-PYLORI-ANTIBIOTIC-RESISTANCE-SEQUENCING-PANEL

CPT 0008U: H. pylori Antibiotic Resistance Panel, Gene Sequence Analysis

CPT-0009U-DEPARRAY-HER2-FISH-TUMOR-CELL-ISOLATION

CPT 0009U: DEPArray HER2 Tumor‑Cell Isolation with FISH Analysis

CPT-0010U-BACTERIAL-TYPING-WHOLE-GENOME-SEQUENCING-MAYO-CLINIC

CPT 0010U: Bacterial Typing by Whole Genome Sequencing, Mayo Clinic

CPT-0011U-CORDANT-CORE-ALGORITHMIC-ORAL-FLUID-DRUG-TEST

CPT 0011U: Cordant CORE™ Oral Fluid Drug Test with Algorithmic Steady‑State Comparison

CPT-0016U-BCR-ABL1-MAJOR-MINOR-FUSION-TRANSCRIPT-TESTING

CPT 0016U: BCR–ABL1 Major and Minor Breakpoint Fusion Transcript Testing

Showing 1–10 of 536

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

CPT 0521U: Seronegative Rheumatoid Arthritis Panel

Sign up for cpt 0521U policy alerts

Billing Code Overview

OpenPayer

CPT 0521U: Seronegative Rheumatoid Arthritis Panel

Sign up for cpt 0521U policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References